LCN2 and breast cancer: In addition, TAMs-released NGAL stimulates the epithelial–mesenchymal transition (EMT) of breast cancer cells, resulting both in their increased motility and transendothelial migration, two events that facilitate their metastatic colonization in the lung [17].